adults have been diagnosed with liver disease
Month 1: Foundation Phase Energy improvements (reported by roughly 80% of community users) Minimal weight changes Better sleep and recovery Month 2: Acceleration Phase Noticeable energy enhancement First weight changes (reported by roughly 60% of community users) Improved exercise performance Month 3: Results Phase Significant body composition changes 5-15 pound weight loss (community-reported among good responders) Measurable metabolic improvements Month 4+: Optimization Phase Stabilized weight loss Enhanced metabolic flexibility Maintained energy improvements Research Supplies for 5-Amino-1MQ Hand-picked storage, injection, and recovery supplies paired with 5-Amino-1MQ protocols
Cyanocobalamin (Vitamin B12) 5000 mcg, Benzyl Alcohol (preservative) 1.0% v/v, Sodium Chloride 0.22% w/v, Ammonium Sulfate 0.1% w/v, Citric Acid 0.01% w/v, Sodium Citrate 0.008% w/v
Oral antibiotic therapy of serious systemic infections
Research will investigate the potential role of C-peptide in conditions beyond diabetes, such as its effects on cardiovascular health, neuroprotection, and wound healing
Every peptide has its strengths for different research projects
